Nickie, You point out that it is difficult to d
Post# of 148172
You point out that it is difficult to demonstrate efficacy in M/M as most recover well without intervention.
Leronlimab succeeded in spite of this difficulty in a trial population of 84 (not that thousands that remdisivir trial had) and still achieved 150% improvement in NEWS2 score, p=0.02.
It will be unconscionable act, with quite a lot of tortuous explanation required, if FDA denies EUA and leronlimab sold to Boris Johnson and Rodrigo Dutertel